Distinct genes related to drug response identified in ER positive and ER negative breast cancer cell lines.
Ontology highlight
ABSTRACT: Breast cancer patients have different responses to chemotherapeutic treatments. Genes associated with drug response can provide insight to understand the mechanisms of drug resistance, identify promising therapeutic opportunities, and facilitate personalized treatment. Estrogen receptor (ER) positive and ER negative breast cancer have distinct clinical behavior and molecular properties. However, to date, few studies have rigorously assessed drug response genes in them. In this study, our goal was to systematically identify genes associated with multidrug response in ER positive and ER negative breast cancer cell lines. We tested 27 human breast cell lines for response to seven chemotherapeutic agents (cyclophosphamide, docetaxel, doxorubicin, epirubicin, fluorouracil, gemcitabine, and pacl
SUBMITTER: Shen K
PROVIDER: S-EPMC3397945 | biostudies-literature | 2012
REPOSITORIES: biostudies-literature
ACCESS DATA